Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
0.3400
0.00 (0.00%)
At close: May 12, 2025, 4:00 PM
0.3400
-0.0001 (-0.01%)
After-hours: May 12, 2025, 7:59 PM EDT
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $1.10 million as of May 12, 2025. Its market cap has increased by 173.97% in one year.
Market Cap
1.10M
Enterprise Value
-2.22M
1-Year Change
173.97%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $161.90M to $1.10M, a decrease of -99.32%. That is a compound annual growth rate of -43.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 500.00K | -77.27% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.43% |
| Dec 31, 2021 | 38.60M | -74.59% |
| Dec 31, 2020 | 151.90M | 413.18% |
| Dec 31, 2019 | 29.60M | 2.78% |
| Dec 31, 2018 | 28.80M | -68.28% |
| Dec 29, 2017 | 90.80M | 83.81% |
| Dec 30, 2016 | 49.40M | -69.49% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |